What is Tagomics?
Founded in 2020 and headquartered in Cambridge, United Kingdom, Tagomics is at the forefront of developing advanced platforms designed to provide comprehensive disease insight and facilitate diagnosis. The company's focus on leveraging technology for enhanced healthcare solutions positions it within the rapidly evolving biotechnology and health-tech sectors. This strategic investment underscores the market's confidence in Tagomics' potential to innovate and scale its offerings in a critical area of medical advancement.
How much funding has Tagomics raised?
Tagomics has raised a total of $8.5M across 1 funding round:
Other Financing Round
$8.5M
Other Financing Round (2024): $8.5M with participation from Calculus Capital, IQ Capital, and Illumina Ventures
Key Investors in Tagomics
Calculus Capital
Calculus Capital is a London-based investment manager specializing in tax-efficient growth capital for UK smaller companies, focusing on high-growth technology, healthcare, and creative industries businesses.
IQ Capital
IQ Capital is a venture capital firm investing in 'deep-tech' across sectors including machine learning, AI, robotics, and advanced engineering, with a focus on companies capable of global market dominance.
Illumina Ventures
Illumina Ventures is a leader in genomics and precision health investing, focused on building an ecosystem that translates investment into innovation to enhance human health and accelerate impactful solutions in genomics.
What's next for Tagomics?
The recent major strategic investment signals a pivotal phase for Tagomics, likely enabling the company to accelerate its product development, expand its market reach, and further solidify its position in the disease insight and diagnosis sector. This capital infusion is expected to fuel innovation, potentially leading to the enhancement of its platform's capabilities and the exploration of new diagnostic applications. The company's trajectory suggests a focus on scaling operations and deepening its impact within the healthcare ecosystem, leveraging its technological advancements for broader clinical adoption and commercial success.
See full Tagomics company page
